SCHEMBL20500337

SCHEMBL20500337

Nc1nccc(N2CCC(NC(=O)OCc3ccccc3)CC2)c1C=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ CTSL P07711 1/20 0.48
▸ CTSB P07858 1/20 0.48
▸ CTSK P43235 1/20 0.48
▸ DPP4 P27487 7/20 0.46
▸ DPP7 Q9UHL4 7/20 0.46
▸ KCNH2 Q12809 4/20 0.46
▸ TGM2 P21980 5/20 0.46
▸ F13A1 P00488 4/20 0.46
▸ TGM1 P22735 4/20 0.46
▸ EPHX1 P07099 1/20 0.44
▸ CNR1 P21554 1/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ JAK1 P23458 1/20 0.43
▸ TYK2 P29597 1/20 0.43
▸ HSD11B1 P28845 1/20 0.42
▸ TGM6 O95932 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20500383 0.82 TSHR (0.47) TSHRALDH1A1GAACTSLCTSB
SCHEMBL20500415 0.81 CKS1B (0.48) CTSKCNR1CNR2JAK2JAK1
SCHEMBL459989 0.75 ALDH1A1 (0.56) TSHRALDH1A1GAACTSLCTSB
SCHEMBL20500350 0.75 SSTR2 (0.40) TSHRALDH1A1GAACTSLCTSB
SCHEMBL6190799 0.75 ALDH1A1 (0.58) TSHRALDH1A1GAACTSLCTSB
SCHEMBL30078473 0.75 TGM2 (0.46) TSHRALDH1A1GAACTSLCTSB
SCHEMBL20500388 0.74 CNR1 (0.43) TSHRALDH1A1GAACTSLCTSB
SCHEMBL1223261 0.74 ALDH1A1 (0.45) TSHRALDH1A1GAACTSLCTSB
SCHEMBL17592966 0.73 TSHR (0.63) TSHRALDH1A1GAACTSLCTSB
SCHEMBL21855497 0.73 CA1 (0.63) TSHRALDH1A1GAACTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11072598-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2021-07-27 — — US disclosed
WO-2018170284-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2018-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11072598-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 TSHR 70/4885ALDH1A1 4626/4885GAA 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback